Zhou, Ting <br/><br/>
Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.  [electronic resource] 

 -  Annals of hematology  Jan 2018 
 - 141-147 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-017-3160-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Incidence<br/>Lung Diseases, Interstitial--chemically induced<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Prednisone--administration & dosage<br/>Retrospective Studies<br/>Rituximab--administration & dosage<br/>Vincristine--administration & dosage